Search Results 1031-1040 of 19136 for creatinine

1. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

   - Creatinine clearance > 20 ml/min. Specific Inclusion Criteria [HLA Desensitization Group]: - Calculated PRA (cPRA) greater than 50%. - Currently, or under ...

2. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   A serum creatinine of ≤1.5 x Upper Limit of Normal ULN OR; Estimated Glomerular Filtration Rate (eGFR) ≥ 60 mL/min/1.73 m2. Liver function defined as ...

3. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant - Mayo Clinic

   Calculated creatinine clearance (using Cockcroft-Gault equation) >= 30 mL/min; Absolute neutrophil count (ANC) >= 1000/mm^3; Platelet count >= 75000/mm^3 ...

4. Panchromoendoscopy using Oral Indigo Carmine Mixed with Polyethylene Glycol Prep - Mayo Clinic

   Known Creatinine >1.2; Cirrhosis; Pregnancy or breast feeding; History of anaphylaxis to any dye; History of bowel surgery or small bowel obstruction; History ...

5. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

   Adequate renal function: Creatinine clearance (CLcr) ≥ 60 mL/min. Adequate liver function: total bilirubin ≤ 1.5 x ULN; alanine aminotransferase (ALT) or ...

6. A Study of APR-246 and Pembrolizumab in Patients with Solid Tumor Malignancies - Mayo Clinic

   Creatinine clearance > 30 mL/min (by Cockcroft-Gault method;; Total serum bilirubin < 1.5 × upper limit of normal (ULN) unless due to Gilbert's syndrome ...

7. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   Serum creatinine ≤1.5×upper limit of normal (ULN), or glomerular filtration rate >25 mL/min, as calculated with the Cockcroft-Gault formula. Serum ...

8. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

   Creatinine ≤ 1.5 times ULN; No uncontrolled high blood pressure; No unstable angina; No symptomatic congestive heart failure; No myocardial infarction with the ...

9. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

   - Creatinine clearance of ≥ 60 milliliters (mL)/minute. - Ability to swallow tablets. - Ability to comply with outpatient treatment, laboratory monitoring ...

10. Testing The Addition Of High Dose, Targeted Radiation To The Usual Treatment For Locally-Advanced Inoperable Non-small Cell Lung Cancer - Mayo Clinic

    - Creatinine clearance >= 25 mL/min by the Cockcroft-Gault (C-G) equation - Subjects with non-malignant pleural effusion are eligible provided the effusion ...